Clareon TruPlus Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorAlcon Research
About this trial
The purpose of this research study is to generate safety and performance data for Clareon TruPlus Monofocal Intraocular Lenses (IOLs). IOLs are medical devices that are implanted in the eye during cataract surgery to restore clear vision after the cloudy natural lens has been removed. IOLs are intended to remain in the eyes for the duration of the patient's lifetime.
Eligibility criteria
Qualifiers
Diagnosed with bilateral cataracts and planned bilateral cataract extraction by routine phacoemulsification.
Potential postoperative BCDVA of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator.
Astigmatism suitable for correction with available toric IOL models.
Other protocol-specified inclusion criteria may apply.
Disqualifiers
Age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and other eye conditions as specified in the protocol.
Moderate to severe dry eye that would affect study measurements.
Other protocol-specified exclusion criteria may apply.
Trial design
Treatments tested in this trial
- Clareon TruPlus Monofocal Non-Toric IOL
- Clareon TruPlus Monofocal Toric IOL
- Phacoemulsification
Treatment groups
122 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov